POULTRY PHARMACEUTICALS MARKET ANALYSIS

Poultry Pharmaceuticals Market, By Product Type (Drugs (VETRIMOXIN, Other Drug Products), Vaccines (INNOVAX, NOBILIS, Poulvac, Other Vaccine Products), and Feed Additives (VIGOSINE, Amnovit, Other Feed Additives)), By Animal Type (Chicken, Turkey, Duck, Goose, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Jun 2023
Code : CMI3879
Pages :180
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Global Poultry Pharmaceuticals Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global poultry pharmaceuticals market over the forecast period. North America is estimated to hold 38.3% of the market share. The growing prevalence of Zoonotic disease and infectious disease directly impacts on the increased demand for the global poultry pharmaceuticals market. For instance, on January 19, 2023, according to the World Health Organization, per year around, 35,172 human deaths and 21,476 human deaths occur due to Zoonotic in North America. The cases of patients suffering from polio in Asia Pacific are reducing because of increasing awareness regarding the prevention of polio and rabies among the population and free immunization camps, which are organized by the government for immunizing the population against infectious and zoonotic disease. Thus, North America is also projected to spur the global poultry pharmaceuticals market growth over the forecast period.

Geographies covered:

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa